Transcenta to Participate in Four Upcoming Conferences
- Written by PR Newswire
SUZHOU, China, Oct. 24, 2022 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical-stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development, and manufacturing of antibody-based therapeutics, announces that the management team will participate in four upcoming investor...
Read more: Transcenta to Participate in Four Upcoming Conferences














